Literature DB >> 22691867

Screening for Coxiella burnetii seroprevalence in chronic Q fever high-risk groups reveals the magnitude of the Dutch Q fever outbreak.

L M Kampschreur1, J C J P Hagenaars, C C H Wielders, P Elsman, P J Lestrade, O H J Koning, J J Oosterheert, N H M Renders, P C Wever.   

Abstract

The Netherlands experienced an unprecedented outbreak of Q fever between 2007 and 2010. The Jeroen Bosch Hospital (JBH) in 's-Hertogenbosch is located in the centre of the epidemic area. Based on Q fever screening programmes, seroprevalence of IgG phase II antibodies to Coxiella burnetii in the JBH catchment area was 10·7% [785 tested, 84 seropositive, 95% confidence interval (CI) 8·5-12·9]. Seroprevalence appeared not to be influenced by age, gender or area of residence. Extrapolating these data, an estimated 40 600 persons (95% CI 32 200-48 900) in the JBH catchment area have been infected by C. burnetii and are, therefore, potentially at risk for chronic Q fever. This figure by far exceeds the nationwide number of notified symptomatic acute Q fever patients and illustrates the magnitude of the Dutch Q fever outbreak. Clinicians in epidemic Q fever areas should be alert for chronic Q fever, even if no acute Q fever is reported.

Entities:  

Mesh:

Year:  2012        PMID: 22691867      PMCID: PMC9151832          DOI: 10.1017/S0950268812001203

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  14 in total

Review 1.  Natural history and pathophysiology of Q fever.

Authors:  D Raoult; Tj Marrie; Jl Mege
Journal:  Lancet Infect Dis       Date:  2005-04       Impact factor: 25.071

2.  Coxiella burnetii infection among blood donors during the 2009 Q-fever outbreak in The Netherlands.

Authors:  Boris M Hogema; Ed Slot; Michel Molier; Peter M Schneeberger; Mirjam H Hermans; Erik J van Hannen; Wim van der Hoek; H Theo Cuijpers; Hans L Zaaijer
Journal:  Transfusion       Date:  2011-07-14       Impact factor: 3.157

3.  Real-time PCR with serum samples is indispensable for early diagnosis of acute Q fever.

Authors:  Peter M Schneeberger; Mirjam H A Hermans; Erik J van Hannen; Jeroen J A Schellekens; Alexander C A P Leenders; Peter C Wever
Journal:  Clin Vaccine Immunol       Date:  2009-12-23

Review 4.  Q fever.

Authors:  Hervé Tissot-Dupont; Didier Raoult
Journal:  Infect Dis Clin North Am       Date:  2008-09       Impact factor: 5.982

5.  Q fever in the Netherlands: an update on the epidemiology and control measures.

Authors:  W van der Hoek; F Dijkstra; B Schimmer; P M Schneeberger; P Vellema; C Wijkmans; R ter Schegget; V Hackert; Y van Duynhoven
Journal:  Euro Surveill       Date:  2010-03-25

6.  Follow-up of 686 patients with acute Q fever and detection of chronic infection.

Authors:  Wim van der Hoek; Bart Versteeg; Jamie C E Meekelenkamp; Nicole H M Renders; Alexander C A P Leenders; Ineke Weers-Pothoff; Mirjam H A Hermans; Hans L Zaaijer; Peter C Wever; Peter M Schneeberger
Journal:  Clin Infect Dis       Date:  2011-06-15       Impact factor: 9.079

7.  Evaluation of a diagnostic algorithm for acute Q fever in an outbreak setting.

Authors:  Mischa M Jager; Gezina Weers-Pothoff; Mirjam H A Hermans; Jamie C E Meekelenkamp; Jeroen J A Schellekens; Nicole H M Renders; Alexander C A P Leenders; Peter M Schneeberger; Peter C Wever
Journal:  Clin Vaccine Immunol       Date:  2011-04-20

8.  Chronic Q fever. Ninety-two cases from France, including 27 cases without endocarditis.

Authors:  P Brouqui; H T Dupont; M Drancourt; Y Berland; J Etienne; C Leport; F Goldstein; P Massip; M Micoud; A Bertrand
Journal:  Arch Intern Med       Date:  1993-03-08

9.  Seroprevalence of Q fever in the United States, 2003-2004.

Authors:  Alicia D Anderson; Deanna Kruszon-Moran; Amanda D Loftis; Geraldine McQuillan; William L Nicholson; Rachel A Priestley; Amanda J Candee; Nicole E Patterson; Robert F Massung
Journal:  Am J Trop Med Hyg       Date:  2009-10       Impact factor: 2.345

10.  Proximity to goat farms and Coxiella burnetii seroprevalence among pregnant women.

Authors:  Wim van der Hoek; Jamie C E Meekelenkamp; Frederika Dijkstra; Daan W Notermans; Ben Bom; Piet Vellema; Ariene Rietveld; Yvonne T H P van Duynhoven; Alexander C A P Leenders
Journal:  Emerg Infect Dis       Date:  2011-12       Impact factor: 6.883

View more
  29 in total

1.  Coxiella burnetii - Pathogenic Agent of Q (Query) Fever.

Authors:  Lutz Gürtler; Ursula Bauerfeind; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Ruth Offergeld; Georg Pauli; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen
Journal:  Transfus Med Hemother       Date:  2013-12-23       Impact factor: 3.747

2.  Coxiella burnetii Epitope-Specific T-Cell Responses in Patients with Chronic Q Fever.

Authors:  Ann E Sluder; Anja Garritsen; Anja Scholzen; Guilhem Richard; Leonard Moise; Eva Hartman; Chantal P Bleeker-Rovers; Patrick M Reeves; Susan Raju Paul; William D Martin; Anne S De Groot; Mark C Poznansky
Journal:  Infect Immun       Date:  2019-09-19       Impact factor: 3.441

3.  Natural Exposure- and Vaccination-Induced Profiles of Ex Vivo Whole Blood Cytokine Responses to Coxiella burnetii.

Authors:  Susan Raju Paul; Anja Scholzen; Ghazel Mukhtar; Stephanie Wilkinson; Peter Hobson; Richard K Dzeng; Jennifer Evans; Jennifer Robson; Rowland Cobbold; Stephen Graves; Mark C Poznansky; Anja Garritsen; Ann E Sluder
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

4.  Chronic Q fever in the Netherlands 5 years after the start of the Q fever epidemic: results from the Dutch chronic Q fever database.

Authors:  Linda M Kampschreur; Corine E Delsing; Rolf H H Groenwold; Marjolijn C A Wegdam-Blans; Chantal P Bleeker-Rovers; Monique G L de Jager-Leclercq; Andy I M Hoepelman; Marjo E van Kasteren; Jacqueline Buijs; Nicole H M Renders; Marrigje H Nabuurs-Franssen; Jan Jelrik Oosterheert; Peter C Wever
Journal:  J Clin Microbiol       Date:  2014-03-05       Impact factor: 5.948

5.  Waning population immunity prior to a large Q fever epidemic in the south of The Netherlands.

Authors:  D A H Brandwagt; T Herremans; P M Schneeberger; V H Hackert; C J P A Hoebe; J Paget; W VAN DER Hoek
Journal:  Epidemiol Infect       Date:  2016-04-14       Impact factor: 4.434

6.  Comparing the impact of two concurrent infectious disease outbreaks on The Netherlands population, 2009, using disability-adjusted life years.

Authors:  R J Brooke; A Van Lier; G A Donker; W Van Der Hoek; M E E Kretzschmar
Journal:  Epidemiol Infect       Date:  2014-01-24       Impact factor: 4.434

7.  Cell-free propagation of Coxiella burnetii does not affect its relative virulence.

Authors:  Runa Kuley; Hilde E Smith; Dimitrios Frangoulidis; Mari A Smits; Hendrik I Jan Roest; Alex Bossers
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

8.  Coverage of the 2011 Q fever vaccination campaign in the Netherlands, using retrospective population-based prevalence estimation of cardiovascular risk-conditions for chronic Q fever.

Authors:  Patricia E Vermeer-de Bondt; Teske Schoffelen; Ann M Vanrolleghem; Leslie D Isken; Marcel van Deuren; Miriam C J M Sturkenboom; Aura Timen
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

9.  The Qure study: Q fever fatigue syndrome--response to treatment; a randomized placebo-controlled trial.

Authors:  Stephan P Keijmel; Corine E Delsing; Tom Sprong; Gijs Bleijenberg; Jos W M van der Meer; Hans Knoop; Chantal P Bleeker-Rovers
Journal:  BMC Infect Dis       Date:  2013-03-27       Impact factor: 3.090

10.  Estimation of acute and chronic Q fever incidence in children during a three-year outbreak in the Netherlands and a comparison with international literature.

Authors:  Edwin N E Slok; Frederika Dijkstra; Esther de Vries; Ariene Rietveld; Albert Wong; Daan W Notermans; Jim E van Steenbergen
Journal:  BMC Res Notes       Date:  2015-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.